Considering that Gal1 is expressed endogenously in damaged tissue of various neurological diseases, and application of hGal1 improves symptoms of those diseases [16,22,41,45-47], hGal1 is a promising therapeutic agent. This evidence concerns the gene LGALS1 and nervous system disorder.